Oindrila Banik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Oindrila Banik has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Earu Banoth
National Institute of Technology Rourkela
6 shared publications - Prasoon Kumar
Department of Biotechnology and Medical Engineering National Institute of Technology Rourkela Rourkela Odisha India
3 shared publications - Santosh Kumar
Centre of Excellence for Nanotechnology, Department of Electronics and Communication Engineering, Koneru Lakshmaiah Education Foundation, Vaddeswaram 522302, Andhra Pradesh, India
3 shared publications - Ayyappasamy Sudalaiyadum Perumal
Department of Bioengineering, Faculty of Engineering, McGill University, Montreal, Québec, H3A 0E9, Canada
2 shared publications - Abhishek Chaurasia
National Institute of Technology Rourkela, Odisha, Rourkela, India
1 shared publication - Amine Abdelkader Kamen
Department of Bioengineering McGill University Montreal Canada
1 shared publication
Latest Publications
- Open Access
- 26 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (5) , 527
Emerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications
Lipid nanoparticles (LNPs) have become the cornerstone of nucleic acid delivery platforms, particularly in RNA-based vaccines and therapeutics. However, the conventional methods of LNP production, which are primarily reliant on microfluidic mixing of aqueous and organic solvent phases, pose limitations in terms of mRNA stability, residual organic contamination, scalability, cost, and environmental impact. These limitations prompted a renewed search for non-conventional strategies with the promise of improving mRNA-LNP encapsulation approaches. These emerging approaches aim to address key bottlenecks, including mRNA hydrolysis-driven degradation, high production losses, and complex downstream purification. Moreover, the ability to decouple LNP synthesis from mRNA encapsulation could enable streamlined, modular manufacturing workflows and customizable payload delivery, including single- or multiple-mRNA payloads, thereby expanding the therapeutic scope of LNPs. This review offers an early insight into the design principles and scalability potential of emerging non-conventional LNP encapsulation approaches, including solvent-free and microfluidics-free methodologies, and pre-built LNP workflows. We also examine trends in emerging LNP encapsulation tools, including high-shear mixing, sonication, membrane contraction, and other approaches. Finally, we extrapolate the suitability of the methods for scale-up approaches and their economic implications based on the process information.
- 26 April 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (5) , 527
Open AccessEmerging Non-Conventional Approaches in mRNA-LNP Formulation for Therapeutic Applications
Lipid nanoparticles (LNPs) have become the cornerstone of nucleic acid delivery platforms, particularly in RNA-based vaccines and therapeutics. However, the conventional methods of LNP production, which are primarily reliant on microfluidic mixing of aqueous and organic solvent phases, pose limitations in terms of mRNA stability, residual organic contamination, scalability, cost, and environmental impact. These limitations prompted a renewed search for non-conventional strategies with the promise of improving mRNA-LNP encapsulation approaches. These emerging approaches aim to address key bottlenecks, including mRNA hydrolysis-driven degradation, high production losses, and complex downstream purification. Moreover, the ability to decouple LNP synthesis from mRNA encapsulation could enable streamlined, modular manufacturing workflows and customizable payload delivery, including single- or multiple-mRNA payloads, thereby expanding the therapeutic scope of LNPs. This review offers an early insight into the design principles and scalability potential of emerging non-conventional LNP encapsulation approaches, including solvent-free and microfluidics-free methodologies, and pre-built LNP workflows. We also examine trends in emerging LNP encapsulation tools, including high-shear mixing, sonication, membrane contraction, and other approaches. Finally, we extrapolate the suitability of the methods for scale-up approaches and their economic implications based on the process information.
- 16 April 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 26 (11) , 16577-16589
Emerging Saliva-Based Biosensing Platforms for Noninvasive Glucose Monitoring: Advances and Challenges—A Review
Saliva-based detection is emerging as one of the most promising non-invasive biosensing platforms for disease diagnosis, particularly for glucose monitoring in diabetes management. As diabetes continues to affect millions worldwide, its burden is disproportionately higher among socioeconomically disadvantaged populations, where access to traditional blood-based diagnostics is often limited. Current self-monitoring practices typically involve finger-prick blood sampling, a method that is both painful and inconvenient, discouraging frequent testing. In contrast, salivary glucose biosensing platforms offer a painless, affordable, and accessible alternative, particularly suited to a resource-limited setting. Glucose present in saliva serves as a key biomarker, providing a convenient medium for monitoring and sensing this chronic condition. This review examines the correlation between salivary and blood glucose levels, with a particular focus on the physiological time lag between them, which can affect the accuracy of real-time biosensing. We evaluate current devices and biosensor technologies designed for salivary glucose detection, focusing on their working principles, detection ranges, sensitivities, and associated engineering and clinical challenges. Additionally, recent innovations such as enzyme-based biosensors and portable diagnostic kits are discussed for their potential to transform diabetes care and enhance healthcare accessibility across diverse populations.
- 16 April 2026
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 26 (11) , 16577-16589
Emerging Saliva-Based Biosensing Platforms for Noninvasive Glucose Monitoring: Advances and Challenges—A Review
Saliva-based detection is emerging as one of the most promising non-invasive biosensing platforms for disease diagnosis, particularly for glucose monitoring in diabetes management. As diabetes continues to affect millions worldwide, its burden is disproportionately higher among socioeconomically disadvantaged populations, where access to traditional blood-based diagnostics is often limited. Current self-monitoring practices typically involve finger-prick blood sampling, a method that is both painful and inconvenient, discouraging frequent testing. In contrast, salivary glucose biosensing platforms offer a painless, affordable, and accessible alternative, particularly suited to a resource-limited setting. Glucose present in saliva serves as a key biomarker, providing a convenient medium for monitoring and sensing this chronic condition. This review examines the correlation between salivary and blood glucose levels, with a particular focus on the physiological time lag between them, which can affect the accuracy of real-time biosensing. We evaluate current devices and biosensor technologies designed for salivary glucose detection, focusing on their working principles, detection ranges, sensitivities, and associated engineering and clinical challenges. Additionally, recent innovations such as enzyme-based biosensors and portable diagnostic kits are discussed for their potential to transform diabetes care and enhance healthcare accessibility across diverse populations.
- 8 January 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nanobioscience
- Vol. 24 (2) , 249-256
Recycling Eggshell Waste Into Calcium Oxide Nanoparticles: A Sustainable Approach for Nanomaterial Synthesis and Potential Applications
Eggshell (ES) wastes have been ranked as the $15^{\text {th}}$ food industry pollution due to the ever-increasing regular consumption of primary dietary products, eggs. Management and treatment of tons of discarded eggshells produced daily on a global scale are realized to be a predicament, and an immediate solution must be advocated to address the pollution. This sets a tone for the recyclability of this biowaste in a myriad of fields, like nanotechnology, biomedical, and environmental pollution control. Calcium carbonate in the shells makes it a safe precursor for producing calcium oxide as a nanomaterial by the top-down approach – calcination. This paper highlights a facile way to procure waste eggshell-derived metal oxide nanoparticles with reproducibility and recyclability. Calcium Oxide Nanoparticles (CaO NPs) obtained at two different calcination temperatures for optimization and this was characterized by SEM, FTIR, XRD, DLS, and Zeta Potential analyzer. CaONPs are less-studied metal oxide nanoparticles but hold promising applications in different fields. Hence, there is a scope for further investigation on the non-toxic, non-hazardous CaO NPs obtained facilely – an effort to minimize and regulate food wastes.
- 8 January 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nanobioscience
- Vol. 24 (2) , 249-256
Recycling Eggshell Waste Into Calcium Oxide Nanoparticles: A Sustainable Approach for Nanomaterial Synthesis and Potential Applications
Eggshell (ES) wastes have been ranked as the $15^{\text {th}}$ food industry pollution due to the ever-increasing regular consumption of primary dietary products, eggs. Management and treatment of tons of discarded eggshells produced daily on a global scale are realized to be a predicament, and an immediate solution must be advocated to address the pollution. This sets a tone for the recyclability of this biowaste in a myriad of fields, like nanotechnology, biomedical, and environmental pollution control. Calcium carbonate in the shells makes it a safe precursor for producing calcium oxide as a nanomaterial by the top-down approach – calcination. This paper highlights a facile way to procure waste eggshell-derived metal oxide nanoparticles with reproducibility and recyclability. Calcium Oxide Nanoparticles (CaO NPs) obtained at two different calcination temperatures for optimization and this was characterized by SEM, FTIR, XRD, DLS, and Zeta Potential analyzer. CaONPs are less-studied metal oxide nanoparticles but hold promising applications in different fields. Hence, there is a scope for further investigation on the non-toxic, non-hazardous CaO NPs obtained facilely – an effort to minimize and regulate food wastes.
- 23 October 2024
- Published by IOP Publishing in Nanotechnology
- Vol. 36 (2) , 022001
Electrically conductive nanomaterials: transformative applications in biomedical engineering—a review
In recent years, significant advancements in nanotechnology have improved the various disciplines of scientific fields. Nanomaterials, like, carbon-based (carbon nanotubes, graphene), metallic, metal oxides, conductive polymers, and 2D materials (MXenes) exhibit exceptional electrical conductivity, mechanical strength, flexibility, thermal property and chemical stability. These materials hold significant capability in transforming material science and biomedical engineering by enabling the creation of more efficient, miniaturized, and versatile devices. The indulgence of nanotechnology with conductive materials in biological fields promises a transformative innovation across various industries, from bioelectronics to environmental regulations. The conductivity of nanomaterials with a suitable size and shape exhibits unique characteristics, which provides a platform for realization in bioelectronics as biosensors, tissue engineering, wound healing, and drug delivery systems. It can be explored for state-of-the-art cardiac, skeletal, nerve, and bone scaffold fabrication while highlighting their proof-of-concept in the development of biosensing probes and medical imaging. This review paper highlights the significance and application of the conductive nanomaterials associated with conductivity and their contribution towards a new perspective in improving the healthcare system globally.
- 23 October 2024
- Published by IOP Publishing in Nanotechnology
- Vol. 36 (2) , 022001
Electrically conductive nanomaterials: transformative applications in biomedical engineering—a review
In recent years, significant advancements in nanotechnology have improved the various disciplines of scientific fields. Nanomaterials, like, carbon-based (carbon nanotubes, graphene), metallic, metal oxides, conductive polymers, and 2D materials (MXenes) exhibit exceptional electrical conductivity, mechanical strength, flexibility, thermal property and chemical stability. These materials hold significant capability in transforming material science and biomedical engineering by enabling the creation of more efficient, miniaturized, and versatile devices. The indulgence of nanotechnology with conductive materials in biological fields promises a transformative innovation across various industries, from bioelectronics to environmental regulations. The conductivity of nanomaterials with a suitable size and shape exhibits unique characteristics, which provides a platform for realization in bioelectronics as biosensors, tissue engineering, wound healing, and drug delivery systems. It can be explored for state-of-the-art cardiac, skeletal, nerve, and bone scaffold fabrication while highlighting their proof-of-concept in the development of biosensing probes and medical imaging. This review paper highlights the significance and application of the conductive nanomaterials associated with conductivity and their contribution towards a new perspective in improving the healthcare system globally.
- 3 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nanobioscience
- Vol. 23 (1) , 140-147
Microfluidic Point-of-Care Diagnostics for Multi-Disease Detection Using Optical Techniques: A Review
The lifestyle of modern society is a major contributing factor for the majority of patients suffering from more than one disease. To Screen and diagnose each of those diseases, there is a great need for portable, and economical diagnostic tools, which are highly stipulated to yield rapid and accurate results using a small volume of the samples such as blood, saliva, sweat, etc. Point-of-care Testing (POCT) is one of the approaches to harvest prompt diagnosis of numerous diseases. The Majority of Point-of-Care Devices (POCD) are developed to diagnose one disease within the specimen. On the other hand, multi-disease detection capabilities in the same point-of-care devices are considered to be an efficient candidate to execute the state-of-the-art platform for multi-disease detection. Most of the literature reviews in this field focus on Point-of-Care (POC) devices, their underlying principles of operation, and their potential applications. It is evident from a perusal of the scholarly works that no review articles have been written on multi-disease detection PoC devices. A review study analyzing the current level and functionality of multi-disease detection POC devices would be of great use to future researchers and device manufacturers. This review paper is addressing the above gap by focusing on various optical techniques like fluorescence, Absorbance, and Surface Plasmon Resonance (SPR) for multi-disease detection by harnessing the microfluidic-based POC device.
- 3 July 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nanobioscience
- Vol. 23 (1) , 140-147
Microfluidic Point-of-Care Diagnostics for Multi-Disease Detection Using Optical Techniques: A Review
The lifestyle of modern society is a major contributing factor for the majority of patients suffering from more than one disease. To Screen and diagnose each of those diseases, there is a great need for portable, and economical diagnostic tools, which are highly stipulated to yield rapid and accurate results using a small volume of the samples such as blood, saliva, sweat, etc. Point-of-care Testing (POCT) is one of the approaches to harvest prompt diagnosis of numerous diseases. The Majority of Point-of-Care Devices (POCD) are developed to diagnose one disease within the specimen. On the other hand, multi-disease detection capabilities in the same point-of-care devices are considered to be an efficient candidate to execute the state-of-the-art platform for multi-disease detection. Most of the literature reviews in this field focus on Point-of-Care (POC) devices, their underlying principles of operation, and their potential applications. It is evident from a perusal of the scholarly works that no review articles have been written on multi-disease detection PoC devices. A review study analyzing the current level and functionality of multi-disease detection POC devices would be of great use to future researchers and device manufacturers. This review paper is addressing the above gap by focusing on various optical techniques like fluorescence, Absorbance, and Surface Plasmon Resonance (SPR) for multi-disease detection by harnessing the microfluidic-based POC device.
- 1 January 2022
- Published by Optica Publishing Group
- p. JTu5B.39
Design and Simulation of Micropillar based Microfluidic platform for the growth of Organoids in-line with Drug Testing
Models derived from the latter, such as spheroids or organoids are more similar to the in-vivo environment and thus should be considered for drug testing. When entwined with a microfluidic platform imply powerful assay advantages like control media flow, minute cell, and reagents requisition during the culture. In this work, the novel approach is to cultivate healthy and diseased organoids in the same microfluidic platform through a controlled microvalve. Design and simulation are performed using AUTOCAD, CLEWIN, and COMSOL. The novel micropillar microfluidic device was fabricated using photolithography followed by soft lithography. The fabricated device is temporarily bonded to a glass slide through the double tape to check the fluid flow. The phenomenon is visualized by subjecting a solution of methylene blue across the device.
- 1 January 2022
- Published by Optica Publishing Group
- p. JTu5B.39
Design and Simulation of Micropillar based Microfluidic platform for the growth of Organoids in-line with Drug Testing
Models derived from the latter, such as spheroids or organoids are more similar to the in-vivo environment and thus should be considered for drug testing. When entwined with a microfluidic platform imply powerful assay advantages like control media flow, minute cell, and reagents requisition during the culture. In this work, the novel approach is to cultivate healthy and diseased organoids in the same microfluidic platform through a controlled microvalve. Design and simulation are performed using AUTOCAD, CLEWIN, and COMSOL. The novel micropillar microfluidic device was fabricated using photolithography followed by soft lithography. The fabricated device is temporarily bonded to a glass slide through the double tape to check the fluid flow. The phenomenon is visualized by subjecting a solution of methylene blue across the device.